Exact Sciences Liabilities 2024

Exact Sciences Aktienanalyse

What does Exact Sciences do?

Exact Sciences Corp is a US-based company specializing in the development, manufacturing, and marketing of diagnostics. It was founded in 1995 by Kevin T. Conroy and is headquartered in Madison, Wisconsin. The company's main focus is on cancer diagnostics. It has developed an innovative test called the Cologuard test, which is a simple, non-invasive method for detecting colorectal cancer. The test can provide accurate results by analyzing a stool sample from the patient. The Cologuard test is FDA approved and recommended by physicians in the US. Exact Sciences has also developed an extensive portfolio of liquid biopsy tests, which can help detect cancer in its early stages by identifying changes in the patient's blood. The company aims to expand its position in the market for non-invasive cancer diagnostics. Originally founded as an oncology diagnostics company specializing in the development of tests for early tumor detection, Exact Sciences expanded its focus to colorectal cancer diagnostics in 2009 after acquiring the rights to a patented biomarker. The company has experienced rapid growth in recent years and has become a leader in the field of non-invasive cancer diagnostics. It has made several acquisitions, including the acquisition of Genomic Health, a provider of cancer diagnostics and molecular tests. Exact Sciences is divided into two business segments: 1. Diagnostics Exact Sciences develops and distributes diagnostics for the detection of various forms of cancer. The company has a range of products on the market, including: - Cologuard: A test for detecting colorectal cancer - Oncotype DX: A test for detecting various types of breast cancer - Oncotype MAP: A test for detecting colorectal and gastric cancer - Oncotype IQ: A platform for detecting various types of cancer 2. Research and Development Exact Sciences also conducts research and development in the field of cancer diagnostics. The company is working on developing tests for detecting many types of cancer in their early stages. It has also formed partnerships with other companies and organizations to support its research in this field. In conclusion, Exact Sciences Corp is an innovative company specializing in the development of diagnostics for the detection of various types of cancer. The company has achieved a strong market position in non-invasive cancer diagnostics and aims to further expand its product range. With the Cologuard test and its other diagnostics, the company has saved many lives and will continue to contribute to the early detection and treatment of cancer in the future. Exact Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Exact Sciences's Liabilities

Exact Sciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Exact Sciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Exact Sciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Exact Sciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Exact Sciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Exact Sciences Stock

What is the level of liabilities of Exact Sciences this year?

Exact Sciences has a debt balance of 3.33 B USD this year.

What were the liabilities of Exact Sciences compared to the previous year?

The liabilities of Exact Sciences have increased by 4.47% increased compared to the previous year.

What are the consequences of high debt for investors of Exact Sciences?

High liabilities can pose a risk for investors of Exact Sciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Exact Sciences?

Low liabilities mean that Exact Sciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Exact Sciences affect the company?

An increase in liabilities of Exact Sciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Exact Sciences affect the company?

A decrease in the liabilities of Exact Sciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Exact Sciences?

Some factors that can influence the liabilities of Exact Sciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Exact Sciences so important for investors?

The liabilities of Exact Sciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Exact Sciences take to modify the liabilities?

To change its liabilities, Exact Sciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Exact Sciences pay?

Over the past 12 months, Exact Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Exact Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Exact Sciences?

The current dividend yield of Exact Sciences is .

When does Exact Sciences pay dividends?

Exact Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Exact Sciences?

Exact Sciences paid dividends every year for the past 0 years.

What is the dividend of Exact Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Exact Sciences located?

Exact Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Exact Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Exact Sciences from 5/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Exact Sciences pay the last dividend?

The last dividend was paid out on 5/8/2024.

What was the dividend of Exact Sciences in the year 2023?

In the year 2023, Exact Sciences distributed 0 USD as dividends.

In which currency does Exact Sciences pay out the dividend?

The dividends of Exact Sciences are distributed in USD.